These findings underscore the ability of advanced natural language processing (NLP) technologies to support reliable cancer staging, potentially aiding clinicians. Despite the encouraging performance, prospective clinical trials and validation across diverse practice settings remain critical to confirming these preliminary outcomes. Nonetheless, this study highlights the promise of LLM-based systems in reinforcing the accuracy of oncologic workflows and lays the groundwork for broader adoption of AI-driven tools in breast cancer management.